Fighting cancer and chronic disease is tiring work for the immune system. When T cells are engaged in this kind of lengthy battle, they can become exhausted, or unable to function properly. One immunotherapy that revitalizes ...
Apr 18, 2022
0
74
Therapies based on engineered immune cells have recently emerged as a promising approach in the treatment of cancer. Compared to traditional drugs, engineered immune cells are more precise and sophisticated in their ability ...
Apr 15, 2022
0
27
Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health, with collaborators at La Jolla Institute for Immunology and elsewhere, have further elucidated how ovarian ...
Apr 11, 2022
0
41
Tiny structures called nanoparticles can be used to carry substances to certain parts of the body—for example, to deliver a chemotherapy drug to a tumor. Although such "nanomedicines" offer hope for improving cancer therapeutics, ...
Mar 11, 2022
0
91
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...
Feb 3, 2022
0
137
A research team at the Department of Pathology, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) in collaboration with Hong Kong and mainland researchers, has revealed an unrecognized function of patient-derived ...
Jan 27, 2022
0
18
Chinese scientists recently reported the key role in tumor survival played by a histone-acetylation-regulated long noncoding RNA called lysosome cell death regulator (LCDR), providing a potential diagnostic and therapeutic ...
Jan 17, 2022
0
8
In normal cells, electrical voltage patterns provide a blueprint for orderly growth. But with cancer, the opposite happens. Marked by a breakdown in the normal electrical patterns generated by the cells, they lose their specialized ...
Jan 11, 2022
0
7
A research group led by Associate Professor Ryoji Yoshida and Professor Hideki Nakayama from the Department of Oral and Maxillofacial Surgery in Kumamoto University (Japan) has analyzed the extracellular vesicles (EVs) of ...
Dec 16, 2021
0
1
Mount Sinai researchers have solved a major mystery in cancer research: How cancer cells remain dormant for years after they leave a tumor and travel to other parts of the body, before awakening to create metastatic cancer.
Dec 13, 2021
0
209
